إعلان
إعلان
MBRX
Moleculin Biotech, Inc.
3.95
USDبرعاية
-0.16
-3.82%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
3.88
-0.07
-1.85%
تقارير أرباح MBRX
النسبة الإيجابية المفاجئة
MBRX تفوق 19 من 33 آخر التقديرات.
58%
التقرير التالي
بيانات التقرير القادم
١٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$7.92
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-53.41%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-15.02%
Moleculin Biotech, Inc. earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, MBRX reported earnings of -17.00 USD per share (EPS) for Q3 25, missing the estimate of -4.97 USD, resulting in a -241.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -7.92 USD, with revenue projected to reach -- USD, implying an نقصان of -53.41% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Moleculin Biotech, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Moleculin Biotech, Inc. reported EPS of -$17.00, missing estimates by -241.88%, and revenue of $0.00, 0% as expectations.
How did the market react to Moleculin Biotech, Inc.'s Q3 2025 earnings?
The stock price moved down -4.43%, changed from $11.35 before the earnings release to $10.85 the day after.
When is Moleculin Biotech, Inc. expected to report next?
The next earning report is scheduled for ١٩ مارس ٢٠٢٦.
What are the forecasts for Moleculin Biotech, Inc.'s next earnings report?
Based on 4
المحللين, Moleculin Biotech, Inc. is expected to report EPS of -$7.92 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان